Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

TC BioPharm Holdings (TCBP)

  • Technical Exchange News
  • Jan. 03, 2024, 07:33 UTC
  • 24
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Renalytix AI (RNLX)

  • Technical Exchange News
  • Jan. 03, 2024, 07:32 UTC
  • 23
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Surrozen Inc (SRZN)

  • Technical Exchange News
  • Dec. 30, 2023, 06:40 UTC
  • 24
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Quince Therapeutics Inc (QNCX)

  • Technical Exchange News
  • Dec. 30, 2023, 06:40 UTC
  • 22
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Genetic Technologies Ltd (GENE)

  • Technical Exchange News
  • Dec. 30, 2023, 06:38 UTC
  • 22
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

DURECT Corporation (DRRX)

  • Technical Exchange News
  • Dec. 30, 2023, 06:38 UTC
  • 22
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Ainos Inc. (AIMD)

  • Technical Exchange News
  • Dec. 30, 2023, 06:37 UTC
  • 22
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Aditx Therapeutics Inc (ADTX)

  • Technical Exchange News
  • Dec. 30, 2023, 06:37 UTC
  • 21
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

DBV Technologies S.A. (DBVT)

  • Technical Exchange News
  • Dec. 29, 2023, 10:23 UTC
  • 22
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Altamira Therapeutics Ltd. (CYTO)

  • Technical Exchange News
  • Dec. 29, 2023, 10:23 UTC
  • 22
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 1217
  • 1218
  • 1219
  • 1220
  • 1221
  • Next

Search

News categories

  • Technical Exchange News(12372)
  • Event(6229)
  • SEC News(274015)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158451)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin